Christopher Posner
PRESIDENT AND CEO · Tvardi Therapeutics, Inc.
IndividualSelling only1 10b5-1 trade
- 2024
- Nov 6, 2024
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Christopher Posner's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- TCO GROUP HOLDINGS, L.P. - $92.50M in INNV purchases and sales in the last 12 months
- IGNITE AGGREGATOR LP - $92.50M in INNV purchases and sales in the last 12 months
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M in MANE purchases and sales in the last 12 months
- Steven Leonard Chapman - $89.87M in NTRA purchases and sales in the last 12 months
- Ugur Sahin - $84.23M in BNTX purchases and sales in the last 12 months
- Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher Posner?
Christopher Posner is a corporate insider, tracked as PRESIDENT AND CEO of Tvardi Therapeutics, Inc. (TVRD). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Christopher Posner last file a Form 4?
The only primary Form 4 on record is dated 6 November 2024.
Has Christopher Posner been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($1K) across all tracked filings.
